Skip to main content

New Leadership Appointments in Obstetrical Services Announced, Effective Oct. 1

Friday, September 27, 2019

New leadership roles in Obstetrical Services in the Department of Ob/Gyn, effective October 1, 2019, were announced today by Matthew D. Barber, MD, MPH, Department Chair. Brenna Hughes, MD, MSc, Associate Professor of Ob/Gyn, will become Chief of the Division of Maternal-Fetal Medicine and Vice Chair for Obstetrics and Quality in the Department of Obstetrics and Gynecology. Dr. Hughes is an internationally recognized maternal-fetal medicine specialist with expertise in perinatal infectious disease. As a testament to her specific expertise, she has helped develop national guidelines on emerging infectious disease outbreaks and their impact on reproduction and pregnancy, including H1N1, Ebola and, most recently, Zika. She is a highly funded clinical investigator, serving as PI of the recently funded SPAN (Study of Pregnancy and Neonatal Health), a multi-site study that will investigate prenatal exposures and genetic factors that impact fetal growth and development and neonatal health, important determinants of life-long health and disease ($5.3 million; NICHD), among others. For the past two years, Dr. Hughes has also served as Chair of the Department’s Quality, Safety and Peer Review Committee, where she has made a significant impact leading the Department’s efforts to provide the highest quality care for women, and to pursue zero harm for our patients and providers. In her new role as Vice Chair for Obstetrics and Quality, we look forward to her leadership as we further expand these quality efforts across the Department and lead our nationally recognized Obstetrical Services.

Chad Grotegut, Md, MHSc, MBA, Associate Professor of Ob/Gyn, will assume the role of Medical Director of the Women’s Clinical Service Unit (CSU) at Duke University Hospital.  Dr. Grotegut has served as the Medical Director for the Duke Birthing Center since 2015, where he has shown extraordinary leadership, and we are excited for him to carry this into his new expanded role overseeing the CSU. Dr. Grotegut is a maternal-fetal medicine specialist whose research focuses on potential mechanisms of abnormal labor, with work on the role of the oxytocin receptor in normal and abnormal labor, and the role of store-operated calcium entry as a mediator of oxytocin-induced uterine contractility. He is to be further congratulated on his recently funded R01 grant (Co-PI, NICHD, $3.2 million) extending this work.